MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Medivation Company Profile (NASDAQ:MDVN)

Consensus Ratings for Medivation (NASDAQ:MDVN) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 14 Buy Rating(s)
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $127.95 (21.48% upside)

Current Analysts' Coverage Summary for Medivation (NASDAQ:MDVN)
Show:
DateFirmActionRatingPrice TargetActions
7/30/2015Stifel NicolausLower Price TargetBuy$146.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Cowen and CompanyLower Price TargetUnderperform$84.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015BTIG ResearchInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015Maxim GroupBoost Price TargetBuy$155.00 -> $168.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Brean CapitalSet Price TargetBuy$142.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015RBC CapitalReiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Citigroup Inc.Reiterated RatingBuy$147.00 -> $145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015JMP SecuritiesReiterated RatingOutperform$143.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Canaccord GenuitySet Price TargetBuy$180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Credit SuisseReiterated RatingOutperform -> Neutral$98.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Jefferies GroupUpgradeHold$136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015BarclaysBoost Price TargetOverweight$133.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015JPMorgan Chase & Co.Boost Price TargetOverweight$130.00 -> $148.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015WedbushBoost Price TargetOutperform$118.00 -> $138.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/24/2014William BlairSet Price TargetBuy$116.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2014Goldman SachsDowngradeBuy -> Neutral$90.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2014Chardan CapitalBoost Price TargetBuy$100.00 -> $122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Sanford C. BernsteinUpgradeMarket Perform -> Outperform$118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Leerink SwannBoost Price Target$104.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingOutperform$104.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2014Needham & Company LLCDowngradeBuy -> Hold$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2014CRT CapitalInitiated CoverageBuy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha